Financials

  • Market Capitalization 215.98 M
  • Employee 228
  • Founded 2008
  • CEO N/A
  • Website www.karyopharm.com
  • Headquarter Delaware, United States
  • FIGI BBG001J272L7
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.34
市销率
0

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3577
OBIO
Orchestra BioMed Holdings, Inc. - Ordinary Shares
3.65 USD-1.08%-6.89%-6.41%+15.14%218.56 M USD
3579
KROS
Keros Therapeutics, Inc. - common stock
11.03 USD+4.35%-5.32%+9.32%-26.95%218.30 M USD
3586
SLGL
Sol-Gel Technologies Ltd. - Ordinary Shares
77.22 USD+2.43%+2.96%+8.23%+809.54%215.15 M USD
3590
NBP
NovaBridge Biosciences - American Depositary Shares
1.85 USD+2.78%-4.15%+20.13%-58.98%213.46 M USD

新闻